New injection aims to shield liver during cancer surgery
NCT ID NCT07150624
Summary
This study is testing whether a specific injection can help protect the liver during and after surgery to remove liver cancer. Researchers want to see if giving this injection before surgery, and then alongside another standard medication after surgery, helps patients' liver function recover better than just getting the standard medication after surgery. The trial will involve 96 patients undergoing a specific type of keyhole liver surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA (HCC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Anhui Provincial Hospital
RECRUITINGHefei, Anhui, 230000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.